Journal for ImmunoTherapy of Cancer (Nov 2021)

31 Serum LAG-3 is associated with improved patient prognosis in high grade serous ovarian cancer

Nicole James,
Katrin Eurich,
Erin Lips,
Payton De La Cruz,
Morgan Woodman,
Jennifer Ribeiro

Affiliations

Nicole James: 1Women and Infants Hospital, Providence, RI, USA
Katrin Eurich: 1Women and Infants Hospital, Providence, RI, USA
Erin Lips: 1Women and Infants Hospital, Providence, RI, USA
Payton De La Cruz: 2Brown University, Providence, RI, USA
Morgan Woodman: 1Women and Infants Hospital, Providence, RI, USA
Jennifer Ribeiro: 1Women and Infants Hospital, Providence, RI, USA

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.031
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal